Reducing the Burden of Oncologic Chemoradiotherapy And Radiation Exposure From Diagnostic Imaging by Utilizing Targeted Immunotherapy in Children, Adolescents and Young Adults With Lymphoma
Latest Information Update: 18 Jan 2024
At a glance
- Drugs Brentuximab vedotin (Primary) ; Cyclophosphamide (Primary) ; Cytarabine (Primary) ; Dacarbazine (Primary) ; Dexamethasone (Primary) ; Doxorubicin (Primary) ; Etoposide (Primary) ; Methotrexate (Primary) ; Nivolumab (Primary) ; Polatuzumab vedotin (Primary) ; Rituximab (Primary) ; Vinblastine (Primary) ; Vincristine (Primary)
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- Acronyms RADICAL
- 12 Dec 2023 Results (n=9) presented at the 65th American Society of Hematology Annual Meeting and Exposition.
- 25 Feb 2022 New trial record